Newgen Software Technologies Reports Unavailability of CMD Amid Health Concerns
Newgen Software Technologies Limited has confirmed that its Chairman and Managing Director, Mr. Diwakar Nigam, has been indisposed due to pneumonitis-related health issues. The disclosure relates to a period where Mr. Nigam was unavailable to discharge his duties in a regular manner for more than forty-five days within a rolling ninety day period, covering the timeframe from April 2026 to June 2026.The company reported that Mr. Nigam was intermittently hospitalized during May 2026 and June 2026 due to his health condition. While unavailable for sustained executive duties, it was noted that he remained available for certain crucial meetings and key decision making as required from time to time. This formal disclosure addresses the nature and duration of his professional unavailability.
Newgen Software Technologies Limited has assured continuity in its business operations. The company stated that necessary steps have been taken to ensure no disruption occurred. The existing Whole-time Directors are attending to all matters requiring attention, and the organization has continued functioning in the ordinary course of business.
Key details regarding the event and management actions are as follows:
| Event Detail | Information |
|---|---|
| Date of Occurrence/Information | June 30, 2026 |
| Time Stamp | The matter was approved by the Board of Directors through circular resolution at 11:27 A.M., following circulation of the board circular note at 11:09 A.M. |
NEWGEN Stock Price Movement
Shares of Newgen Software Technologies Limited are edging higher to ₹471.10 as of 11:54 AM today, gaining 0.61% in live trading. The stock is currently within an intraday range marked by a low of ₹465.90 and a high of ₹472.80, amidst 234,059 shares traded.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.